glp 1 agonist anesthesia Updated guidance for patients using GLP-1/GIP receptor agonists Exploring the Side Effects of

The GLP-1 Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives Stephs Note: Are you trying to figure out what all the hub bub is about the dazzling new weight-loss drugs

Diabetol Metab Syndr 17 , 179 (2025)

Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon Pharma, Clariane, Compass, Dainippon Sumitomo Pharma, Esteve, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Intra-Cellular therapies, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Mitsubishi Tanabe Pharma, Newraxpharm, Newron, Novartis, Organon, Orion Corporation, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work

Diabetic eye problems (diabetic retinopathy)

Last, we call upon clinicians, researchers, regulators, and industry stakeholders to address existing gaps in accessibility and explore opportunities for enhancing the use of GLP-1R agonists in both individualized care and broader public health contexts

In a few weeks, millions of seniors on Medicare will be able to access the medicines for $50 a month out of pocket